Answers are grounded in this paper and cite their sources.
Molecular study highlighted clinical features of Brown-Vialetto-Van Laere syndrome in Indian cases, suggesting riboflavin therapy may be effective.
Brown-Vialetto- Van Laere (BVVL) syndrome is neurodegenerative condition, characterised by ponto-bulbar palsy and sensori-neural hearing loss. Since, this is a rare condition with common sign and symptoms, diagnosis is usually missed or delayed. The above condition is Riboflavin transporter defect which responds to riboflavin therapy. Molecular study confirmed the diagnosis and found recurrent pathogenic variation c.1238 C>A; p Val 413 Asp in exon 5 of SLC52A3 gene in present case. We tabulated all Indian cases of BVVL and highlighted their clinical features and genotype. BVVL type 1 is the most common type, reported from Indian patients.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: